-
-
Overview
-
Omaveloxolone (RTA408) is a potent Nrf2 transcription factor activator by targeting KEAP1 to prevent Nrf2 ubiquitination and degradation. It exhibits potent antioxidative and anti-inflammatory activities. Omaveloxolone treatment significantly improves mitochondrial function of Friedreich's Ataxia patient-derived cells.
Please contact us at for specific academic pricing.
-
- Properties
-
Overview